Specialists in Reproductive Medicine & Surgery, P.A. – FDA 483, Apr 15, 2022
An FDA inspection of Specialists in Reproductive Medicine & Surgery, P.A. in Fort Myers, FL, revealed significant deficiencies in their donor screening and testing procedures for reproductive tissues. Observations included improper timing of communicable disease agent testing for donor specimens, inadequate screening of donors for communicable disease risk factors, and a lack of established procedures for screening and testing HCT/P donors for specific viruses like Zika and West Nile. This indicates a need for improved controls to ensure donor eligibility and product safety.
- Inspection date
- April 15, 2022
- Product type
- biologics
ID · 56d4bd30-bc43-4aa4-836a-f6423f5ef07f
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.